1Grossin L,Charissoux JL,Teissier MP,et al.Selective killing of osteosarcoma cells in culture after retroviral mediated gene transfer of a herpes simplex thymidine kinase suicide gene[J].Anticancer Res,1999,19:71-76.
2Charissoux JL,Grossin L,Leboutet MJ,et al.Treatment of experimental osteosarcoma tumors in rat by herpes simplex thymidine kinase gene transfer and ganciclovir[J].Anticancer Res,1999,19:77-80.
3Seto M,Yamazaki T,Sonoda J,et al,Suppression of tumor growth and pulmonary metastasis in murine osteosarcoma using gene therapy[J].Oncol Rep,2002,9:337-340.
4Zheng X,Lundberg M,Karlsson A,et al.Lipid-mediated protein delivery of suicide nucleoside kinases[J].Cancer Res,2003,63:6909-6913.
5Ketola A,Maatta AM,Pasanen T,et al.Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy[J].Int J Mol Med,2004,13:705-710.
6Ramnaraine M,Pan W,Goblirsch M,et al.Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene[J].Cancer Res,2003,63:6847-6854.
7Zheng Y,Johansson M,Karlsson A.Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol[J].Biochem Biophys Res Commun,2001,289:229-233.
8Zheng X,Johansson M,Karlsson A.Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea[J].Mol Pharmacol,2001,60:262-266.
9Oosterhoff D,Witlox MA,Van Beusechem VW,et al.Gene-directed enzyme prodrug therapy for osteosarcoma:sensitization to CPT-11 in vitro and in vivo by adenoviral delivery of a gene encoding secreted carboxylesterase-2[J].Mol Cancer Ther,2003,2:765-771.
10Balzarini J,Ostrowski T,Goslinski T,et al.Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines[J].Gene Ther,2002,9:1173-1182.